IMM 11.9% 29.5¢ immutep limited

the facts about prr trials, page-3

  1. 244 Posts.
    boiler, it's hardly fda imposed (i.e. fda making them call it a phase 2 trial).

    it is just an issue with having to classify a trial as phase 2/3 due to website design

    be careful with how you word things. i have no issue with you finding that it was changed to a phase 2 trial, but do not promote it as such without proof.

    now that we have confirmation that in fact nothing has changed, it would be nice to see you accept this as fact, and retract your statement that

    "Therefore no clinical error, and the information the site contains is FDA imposed."

    also, you line: "We have had interim data and now we are a Phase 2 ???????" is implying that after interim data, the fda has imposed CANVAS to be a phase II. while you are not directly saying this, one can only assume it from the way you have posted. again, for the sake of being impartial, you should acknowledge that this is not true.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
29.5¢
Change
-0.040(11.9%)
Mkt cap ! $428.5M
Open High Low Value Volume
32.0¢ 33.0¢ 28.0¢ $7.278M 23.75M

Buyers (Bids)

No. Vol. Price($)
4 53192 29.5¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 41048 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.